Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
Abstract Background Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and studies show that many healthcare institutions confront barriers while im...
Enregistré dans:
Auteurs principaux: | Kashif Hussain, Rahila Ikram, Gul Ambreen, Muhammad Sohail Salat |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d8a77add683043fc942fb818ac2a6fe7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Assessment of pharmacists' perception toward continuing education
par: Nouf M Alharthi, et autres
Publié: (2021) -
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
par: Christoph Tiede, et autres
Publié: (2021) -
Pharmacists and telemedicine: an innovative model fulfilling Sustainable Development Goals (SDGs)
par: Nadia Bukhari, et autres
Publié: (2021) -
Bibliometric analysis of pharmacist’s research on antimicrobial stewardship in Japan: an interrupted time series analysis on the implementation of the certification system for infection control pharmacists
par: Masayuki Maeda, et autres
Publié: (2021) -
Physicians' views on cardiovascular disease risk prevention services by pharmacists and potential for collaboration
par: Hadi A. Almansour, et autres
Publié: (2021)